No significant safety concerns were found in the first four patients participating in a Phase 1/2 trial assessing…
Articles by Steve Bryson, PhD
Based on MRI scans, Huntington’s disease patients with major cognitive impairments have reduced gray matter volume and…
A single injection of the protein CDNF — cerebral dopamine neurotrophic factor — into the brains of rats with…
Administration of the hormone erythropoietin (EPO) using a gene transfer method improved spatial…
Teva Pharmaceuticals’ Austedo (deutetrabenazine tablets) has been approved by China’s …
A DNA-binding compound can reverse the repeat expansion mutation that is associated with Huntington’s disease, an early…
In a proof-of-principle experiment, a new gene therapy approach with the potential to treat people with Huntington’s disease has…
A potential treatment called RG6042, which target all forms of the mutant huntingtin protein (…
Neural stem cell researchers at the University of California, Irvine, (UCI) will collaborate…
Raman spectroscopy, an analysis technique that uses light, identified a specific molecular fingerprint in the blood of people…